Division of Allergy and Immunology News
Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Medicine, Division of Allergy and Immunology. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards and honors.
A team of scientists has identified new genetic regions associated with asthma in people of African ancestry, according to a study published in Nature Communications.
Feinberg investigators are conducting basic science research, epidemiological studies and drug trials of new therapies for food allergies to uncover the breadth of the problem, understand the basic cellular pathways and develop new avenues of treatment.
Infant and childhood food allergy, whose cause has long been a mystery, has now been linked to a mix of environmental and genetic factors that must coexist to trigger the allergy, reports a new Northwestern Medicine study.
A drug originally designed for chemotherapy may reduce allergic responses for a variety of allergens, according to a study published in the Journal of Allergy and Clinical Immunology.
The previously unknown cause of anti-phosphatidylethanolamine (aPE) autoimmunity was discovered in a Northwestern Medicine study published in PNAS.
Omar Bushara, first-year MD/MPH student, discusses how spending a year teaching biology on Chicago's South Side crystallized his interest in public health.
- 10.27.2017New research has found that almost half of people diagnosed with food allergies developed this condition in adulthood, with Hispanic, Asian, and black individuals most at risk.
- 10.12.2017On Tuesday, Nationals manager Dusty Baker said ace Stephen Strasburg wouldn’t start because the pitcher was under the weather, citing the change in climate, the hotel air conditioning and Chicago mold. On Wednesday, Baker changed his story and started Strasburg against the Cubs in Game 4 of the National League Division Series.
Northwestern Medicine scientists have discovered that a unique population of immune cells play a key role in the development of pulmonary fibrosis, a fatal lung disease.
A cancer drug for certain types of leukemia and lymphoma can also prevent reactions to some of the most common airborne allergies, according to a recent Northwestern Medicine study.